21世纪经济报道记者季媛媛礼来在GLP-1药物市场的凶猛攻势,让诺和诺德不得不两次下调年度预期,而美国药房货架上,替尔泊肽的身影正变得越来越常见。8月7日,礼来发布2025年上半年财报数据显示,上半年营收282.862亿美元,同比增长41%。从地区分布来看,2025年前六个月美国市场收入193.04亿美元,同比增长43%;欧洲市场收入49.63亿美元,同比增长74%;日本市场收入9.23亿美元,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.